Alberto Inga

Overview

Best Publications

• The expanding universe of p53 targets

  Daniel Menendez;Alberto Inga;Michael A. Resnick

  687
  Citations

• A highly specific SpCas9 variant is identified by in vivo screening in yeast.

  Antonio Casini;Michele Olivieri;Gianluca Petris;Claudia Montagna

  450
  Citations

• Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence

  Alberto Inga;Francesca Storici;Thomas A. Darden;Michael A. Resnick

  239
  Citations

• The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis

  Bernard Leroy;Jean Louis Fournier;Chikashi Ishioka;Paola Monti

  206
  Citations

• Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity

  Michael A. Resnick;Alberto Inga

  186
  Citations

• p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.

  Paola Campomenosi;Paola Monti;Anna Aprile;Angelo Abbondandolo;Angelo Abbondandolo

  173
  Citations

• Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway.

  Tina Uroda;Eleni Anastasakou;Annalisa Rossi;Jean-Marie Teulon

  168
  Citations

• Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation

  Daniel J. Tomso;Alberto Inga;Daniel Menendez;Gary S. Pittman

  145
  Citations

• Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity.

  Zdenek Andrysik;Zdenek Andrysik;Matthew D Galbraith;Matthew D Galbraith;Anna L Guarnieri;Anna L Guarnieri;Sara Zaccara

  140
  Citations

• Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53

  Jennifer J. Jordan;Jennifer J. Jordan;Daniel Menendez;Alberto Inga;Maher Nourredine

  135
  Citations

• The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.

  Elisa Latorre;Elisa Latorre;Stephana Carelli;Ivan Raimondi;Vito D'Agostino

  127
  Citations

• The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes.

  Daniel Menendez;Alberto Inga;Michael A. Resnick

  103
  Citations

• More targets, more pathways and more clues for mutant p53

  Sonia Iolanda Garritano;A Inga;Federica Gemignani;Stefano Landi

  98
  Citations

• A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network

  Daniel Menendez;Oliver Krysiak;Alberto Inga;Bianca Krysiak

  95
  Citations

• Altered-Function p53 Missense Mutations Identified in Breast Cancers Can Have Subtle Effects on Transactivation

  Jennifer J. Jordan;Alberto Inga;Kathleen Conway;Sharon Edmiston

  90
  Citations

• Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.

  Paola Monti;Chiara Perfumo;Alessandra Bisio;Yari Ciribilli

  90
  Citations

• Tumour p53 mutations exhibit promoter selective dominance over wild type p53.

  Paola Monti;Paola Campomenosi;Paola Campomenosi;Yari Ciribilli;Raffaella Iannone

  87
  Citations

• Functional evolution of the p53 regulatory network through its target response elements

  Anil G. Jegga;Alberto Inga;Daniel Menendez;Bruce J. Aronow

  85
  Citations

• A functional genetic study identifies HAND1 mutations in septation defects of the human heart

  Stella Marie Reamon-Buettner;Yari Ciribilli;Ilaria Traverso;Beate Kuhls

  81
  Citations

• p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay

  Alberto Inga;Paola Monti;Gilberto Fronza;Tom Darden

  80
  Citations